Patent · US Active

Meganuclease variants cleaving a DNA target sequence from the mouse ROSA26 locus and uses thereof

US8426177B2 · kind B2 · utility

4Cited by
0References
1Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJun 6, 2008
Grant dateApr 23, 2013
Priority date
Expiry dateApr 24, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA01K2227/105
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

An I-CreI variant, wherein one of the two I-CreI monomers has at least two substitutions, one in each of the two functional subdomains of the LAGLIDADG (SEQ ID NO: 150) core domain situated respectively from positions 26 to 40 and 44 to 77 of I-CreI, said variant being able to cleave a DNA target sequence from the mouse ROSA26 locus. Use of said variant and derived products for the engineering of transgenic mice and recombinant mouse cell lines expressing an heterologous protein of interest.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.